I N MYELOMA, THE ROLE of the bone marrow microenvironment has been shown to be of increasing importance in supporting the malignant plasma cell.[1][1] [2][2] Specifically, nonmalignant stromal cells in the bone marrow from myeloma patients have been shown to promote the growth and prevent the